本页面由Tiger Trade Technology Pte. Ltd.提供服务

Nurix Therapeutics

26.72
-0.3300-1.22%
盘前27.200.4767+1.78%04:04 EDT
成交量:148.59万
成交额:4,018.28万
市值:27.63亿
市盈率:-7.84
高:27.50
开:27.41
低:26.70
收:27.05
52周最高:28.23
52周最低:8.20
股本:1.03亿
流通股本:9,504.52万
量比:1.26
换手率:1.56%
股息:- -
股息率:- -
每股收益(TTM):-3.4102
每股收益(LYR):-3.0514
净资产收益率:-80.30%
总资产收益率:-40.06%
市净率:6.86
市盈率(LYR):-8.76

数据加载中...

2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/31

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/10

重要事件披露

Form 8-K - Current report
2026/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/08

重要事件披露

Form 8-K - Current report
2026/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

重要事件披露

Form 8-K - Current report